Xbrane Biopharma AB (publ)
SSE:XBRANE.ST
2.085 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 65.402 | 193.994 | 295.18 | 243.139 | 164.197 | 100.972 | 7.903 | 31.338 | 2.688 | 6.201 | 8.877 | 0.365 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 65.402 | 193.994 | 295.18 | 243.139 | 164.197 | 100.972 | 7.903 | 31.338 | 2.688 | 6.201 | 8.877 | 0.365 |
| Net Receivables
| 71.178 | 47.456 | 50.253 | 58.365 | 5.889 | 10.489 | 17.133 | 6.714 | 4.585 | 0.005 | 0 | 0.266 |
| Inventory
| 106.856 | 50.26 | 215.573 | 0 | 0 | 5.525 | 3.065 | 2.497 | 0.161 | 0 | 0 | 0 |
| Other Current Assets
| 218.257 | 221.814 | 0.002 | 72.978 | 77.851 | 55.162 | -0.001 | 2.977 | 0 | 0.35 | 0.319 | 0.026 |
| Total Current Assets
| 461.693 | 513.524 | 561.008 | 374.482 | 247.937 | 161.659 | 28.1 | 43.526 | 7.433 | 6.556 | 9.195 | 0.657 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 88.2 | 70.782 | 73.801 | 14.134 | 16.208 | 16.745 | 18.569 | 16.581 | 10.024 | 0.133 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 58.453 | 60.76 | 59.838 | 57.36 | 48.906 | 51.848 | 0 | 0 | 0 |
| Intangible Assets
| 99.67 | 101.995 | 49.672 | 4.083 | 5.053 | 5.773 | 6.297 | 8.462 | 6.026 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 99.67 | 101.995 | 49.672 | 62.536 | 65.813 | 65.611 | 63.657 | 57.368 | 57.873 | 0 | 0 | 0 |
| Long Term Investments
| 3.945 | 3.945 | 3.945 | 12.61 | 8.982 | 8.871 | 0.635 | 0.635 | 0 | 0 | 0 | 0 |
| Tax Assets
| -99.67 | -3.945 | -3.945 | -12.61 | -8.982 | -8.871 | -0.635 | -0.635 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 99.67 | 4.213 | 3.945 | 12.611 | 8.982 | 8.87 | 0.634 | 0.635 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets
| 191.815 | 176.99 | 127.418 | 89.281 | 91.003 | 91.226 | 82.86 | 74.584 | 67.897 | 0.133 | 0 | 0 |
| Total Assets
| 653.508 | 690.515 | 688.427 | 463.763 | 338.94 | 252.885 | 110.96 | 118.11 | 75.331 | 6.689 | 9.195 | 0.657 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 30.974 | 23.297 | 41.393 | 29.546 | 21.097 | 30.908 | 10.541 | 2.364 | 4.763 | 0.114 | 0.216 | 0.181 |
| Short Term Debt
| 75.871 | 9.162 | 7.905 | 2.265 | 3.156 | 45.562 | -1.945 | -0.399 | 10.264 | 0 | 0 | 0 |
| Tax Payables
| 2.49 | 2.185 | 1.775 | 1.321 | 1.117 | 0.123 | 0.792 | 0.094 | 0.059 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 136.063 | 74.976 | 52.442 | 30.186 | 0.123 | 1.945 | 0.399 | -10.264 | 0 | 0 | 0 |
| Other Current Liabilities
| 219.712 | 68.047 | 95.393 | 104.74 | 85.176 | 84.789 | 7.351 | 3.521 | 18.642 | 0.277 | 0.29 | 0.388 |
| Total Current Liabilities
| 326.557 | 236.569 | 219.667 | 188.993 | 139.615 | 161.382 | 17.892 | 5.884 | 23.405 | 0.391 | 0.505 | 0.569 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 112.897 | 29.058 | 36.476 | 3.995 | 6.281 | 4.159 | 1.119 | 4.286 | 4.064 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 8.257 | 4.173 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | -8.257 | -4.173 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 42.719 | 0 | 0.543 | 13.067 | 8.721 | 4.274 | 3.544 | 0.638 | 0.353 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 155.616 | 29.058 | 37.019 | 17.062 | 15.002 | 8.433 | 4.663 | 4.924 | 4.417 | 0 | 0 | 0 |
| Total Liabilities
| 482.173 | 265.627 | 256.686 | 206.055 | 154.617 | 169.815 | 22.555 | 10.809 | 27.821 | 0.391 | 0.505 | 0.569 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.357 | 3.147 | 0 | 0 | 0 |
| Common Stock
| 6.683 | 6.166 | 5.614 | 4.977 | 3.456 | 1.419 | 1.335 | 1.066 | 0.5 | 0.1 | 0.1 | 0.123 |
| Retained Earnings
| -1,273.999 | -885.827 | -713.313 | -524.938 | -273.941 | -107.903 | -94.667 | -56.314 | -23.026 | -11.181 | -8.409 | -7.557 |
| Accumulated Other Comprehensive Income/Loss
| 10.121 | 10.322 | 5.165 | 3.945 | 6.719 | 5.548 | 1.862 | -0.357 | -3.147 | -0 | -0 | 0 |
| Other Total Stockholders Equity
| 1,428.53 | 1,294.227 | 1,134.275 | 773.724 | 448.089 | 184.006 | 179.875 | 162.55 | 70.035 | 17.379 | 16.999 | 7.522 |
| Total Shareholders Equity
| 171.335 | 424.888 | 431.741 | 257.708 | 184.323 | 83.07 | 88.405 | 107.301 | 47.509 | 6.298 | 8.69 | 0.088 |
| Total Equity
| 171.335 | 424.888 | 431.741 | 257.708 | 184.323 | 83.07 | 88.405 | 107.301 | 47.509 | 6.298 | 8.69 | 0.088 |
| Total Liabilities & Shareholders Equity
| 653.508 | 690.515 | 688.427 | 463.763 | 338.94 | 252.885 | 110.96 | 118.11 | 75.331 | 6.689 | 9.195 | 0 |